Correlation Between Franklin Templeton and Franklin Biotechnology

Can any of the company-specific risk be diversified away by investing in both Franklin Templeton and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Templeton and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Templeton Smacs and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Franklin Templeton and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Templeton with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Templeton and Franklin Biotechnology.

Diversification Opportunities for Franklin Templeton and Franklin Biotechnology

0.73

Correlation Coefficient

Franklin Templeton  Franklin Biotechnology

Poor diversification

The 3 months correlation between Franklin and Franklin is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Templeton Smacs and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Franklin Templeton is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Templeton Smacs are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Franklin Templeton i.e., Franklin Templeton and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Franklin Templeton and Franklin Biotechnology

Assuming the 90 days horizon Franklin Templeton Smacs is expected to generate 0.56 times more return on investment than Franklin Biotechnology. However, Franklin Templeton Smacs is 1.8 times less risky than Franklin Biotechnology. It trades about -0.04 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about -0.2 per unit of risk. If you would invest  892.00  in Franklin Templeton Smacs on October 23, 2024 and sell it today you would lose (25.00) from holding Franklin Templeton Smacs or give up 2.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Franklin Templeton Smacs  vs.  Franklin Biotechnology Discove

Franklin Templeton Smacs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Templeton Smacs has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Franklin Templeton is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Franklin Templeton and Franklin Biotechnology

The main advantage of trading using opposite Franklin Templeton and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Templeton position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.

The idea behind Franklin Templeton Smacs and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.